交易 Mind Medicine (MindMed) Inc. Subordinate Voting Shares - MNMD CFD
新增到我的最愛- 概括
- 曆史數據
- 活動
- 收入報表
- 資産負債表
- 現金流
- 所有權
交易條件
價差 | 0.05 | ||||||||
多頭倉位隔夜費用
多頭倉位隔夜費用
前往平台 | -0.026207% | ||||||||
空頭倉位隔夜費用
空頭倉位隔夜費用
前往平台 | 0.003985% | ||||||||
隔夜費時間 | 22:00 (UTC) | ||||||||
最小成交量 | 0.01 | ||||||||
貨幣 | USD | ||||||||
保證金 | 5% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
Mind Medicine (MindMed) Inc ESG Risk Ratings
High Medium Low Negligible
“D”分數表示相對 ESG 表現較差,公開報告重要 ESG 數據的透明度不足。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 關閉 | 更改 | 變化 (%) | 打開 | 高 | 低 |
---|---|---|---|---|---|---|
Nov 28, 2023 | 3.04 | 0.05 | 1.67% | 2.99 | 3.09 | 2.89 |
Nov 27, 2023 | 3.01 | 0.09 | 3.08% | 2.92 | 3.09 | 2.92 |
Nov 24, 2023 | 2.92 | 0.18 | 6.57% | 2.74 | 3.00 | 2.74 |
Nov 22, 2023 | 2.73 | 0.05 | 1.87% | 2.68 | 2.76 | 2.64 |
Nov 21, 2023 | 2.66 | 0.03 | 1.14% | 2.63 | 2.69 | 2.59 |
Nov 20, 2023 | 2.73 | 0.21 | 8.33% | 2.52 | 2.74 | 2.52 |
Nov 17, 2023 | 2.57 | 0.15 | 6.20% | 2.42 | 2.57 | 2.42 |
Nov 16, 2023 | 2.43 | -0.13 | -5.08% | 2.56 | 2.58 | 2.40 |
Nov 15, 2023 | 2.57 | -0.02 | -0.77% | 2.59 | 2.74 | 2.57 |
Nov 14, 2023 | 2.59 | 0.10 | 4.02% | 2.49 | 2.63 | 2.47 |
Nov 13, 2023 | 2.41 | -0.05 | -2.03% | 2.46 | 2.48 | 2.39 |
Nov 10, 2023 | 2.48 | 0.00 | 0.00% | 2.48 | 2.51 | 2.45 |
Nov 9, 2023 | 2.51 | -0.16 | -5.99% | 2.67 | 2.68 | 2.51 |
Nov 8, 2023 | 2.66 | -0.11 | -3.97% | 2.77 | 2.77 | 2.64 |
Nov 7, 2023 | 2.80 | -0.10 | -3.45% | 2.90 | 2.92 | 2.75 |
Nov 6, 2023 | 2.88 | -0.14 | -4.64% | 3.02 | 3.12 | 2.76 |
Nov 3, 2023 | 3.07 | 0.36 | 13.28% | 2.71 | 3.10 | 2.68 |
Nov 2, 2023 | 2.69 | 0.20 | 8.03% | 2.49 | 2.69 | 2.49 |
Nov 1, 2023 | 2.48 | -0.04 | -1.59% | 2.52 | 2.52 | 2.43 |
Oct 31, 2023 | 2.53 | 0.03 | 1.20% | 2.50 | 2.63 | 2.50 |
Mind Medicine (MindMed) Inc. Subordinate Voting Shares Events
时间(协调世界时) (UTC) | 國家 | 事件 |
---|---|---|
Thursday, March 7, 2024 | ||
时间(协调世界时) (UTC) 10:59 | 國家 CA
| 事件 Q4 2023 Mind Medicine (MindMed) Inc Earnings Release Q4 2023 Mind Medicine (MindMed) Inc Earnings ReleaseForecast(預報) -上一頁 - |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2019 | |
---|---|---|---|---|---|
總收入 | 0 | 0 | 0 | 0 | 0 |
總營業費用 | 66.331 | 93.854 | 33.03 | 1.10593 | 5.42921 |
銷售/一般/行政費用,總計 | 30.162 | 59.065 | 14.399 | 0.457414 | 3.10517 |
研究與開發 | 32.969 | 34.789 | 18.631 | 2.04904 | |
Depreciation / Amortization | 3.2 | 0.006625 | 0.275 | ||
利息費用(收入) - 淨運營 | |||||
營業收入 | -66.331 | -93.854 | -33.03 | -1.10593 | -5.42921 |
利息收入(費用),非經營淨值 | 1.69 | -0.445 | -0.907 | 0 | 0.02751 |
其他,淨值 | 7.845 | 0.106 | 0 | -0.0725 | |
稅前淨收入 | -56.796 | -94.193 | -33.937 | -1.10593 | -5.47421 |
稅後淨收入 | -56.796 | -93.036 | -33.937 | -1.10593 | -5.47421 |
未計算非常項目前的淨收益 | -56.796 | -93.036 | -33.937 | -1.10593 | -5.47421 |
淨收入 | -56.796 | -93.036 | -33.937 | -1.10593 | -5.47421 |
普通股股東可獲收益 (不含非經常性項目) | -56.796 | -93.036 | -33.937 | -1.10593 | -5.47421 |
普通股股東可獲收益 (含非經常性項目) | -56.796 | -93.036 | -33.937 | -1.10593 | -5.47421 |
攤薄淨收入 | -56.796 | -93.036 | -33.937 | -1.10593 | -5.47421 |
攤薄後加權平均股 | 30.8575 | 27.3785 | 17.7489 | 0.37943 | 6.92954 |
扣除特別項目的每股攤薄盈利 | -1.84059 | -3.39815 | -1.91206 | -2.91472 | -0.78998 |
每股正常攤薄盈利 | -1.84059 | -3.39815 | -1.91206 | -1.22299 | -0.78998 |
異常費用(收入) | 0.64189 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 0 | 0 | 0 | 0 | 0 |
總營業費用 | 29.184 | 20.862 | 13.9 | 16.983 | 16.943 |
銷售/一般/行政費用,總計 | 14.407 | 8.263 | 5.07 | 9.211 | 7.617 |
研究與開發 | 13.977 | 11.799 | 8.03 | 6.972 | 8.526 |
營業收入 | -29.184 | -20.862 | -13.9 | -16.983 | -16.943 |
利息收入(費用),非經營淨值 | 1.558 | 1.232 | 1.153 | 0.498 | -0.007 |
其他,淨值 | -1.504 | -5.185 | 7.844 | 0 | -0.007 |
稅前淨收入 | -29.13 | -24.815 | -4.903 | -16.485 | -16.957 |
稅後淨收入 | -29.13 | -24.815 | -4.903 | -16.485 | -16.957 |
未計算非常項目前的淨收益 | -29.13 | -24.815 | -4.903 | -16.485 | -16.957 |
淨收入 | -29.13 | -24.815 | -4.903 | -16.485 | -16.957 |
普通股股東可獲收益 (不含非經常性項目) | -29.13 | -24.815 | -4.903 | -16.485 | -16.957 |
普通股股東可獲收益 (含非經常性項目) | -29.13 | -24.815 | -4.903 | -16.485 | -16.957 |
攤薄淨收入 | -29.13 | -24.815 | -4.903 | -16.485 | -16.957 |
攤薄後加權平均股 | 38.5764 | 38.0773 | 37.7314 | 29.2963 | 28.2434 |
扣除特別項目的每股攤薄盈利 | -0.75513 | -0.6517 | -0.12994 | -0.5627 | -0.60039 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -0.75513 | -0.6517 | -0.12994 | -0.5627 | -0.60039 |
Depreciation / Amortization | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 |
異常費用(收入) |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2019 | |
---|---|---|---|---|---|
流動資産總額 | 146.055 | 137.215 | 81.519 | 2.84093 | 6.73654 |
現金和短期投資 | 142.142 | 133.539 | 80.094 | 0.017347 | 3.01645 |
現金等價物 | 0.017347 | ||||
短期投資 | |||||
應收賬款總額,淨額 | 0.004914 | ||||
預付的費用 | 3.913 | 3.676 | 1.425 | 0.020812 | 0.0342 |
總資産 | 169.993 | 164.002 | 81.519 | 2.84093 | 11.9615 |
物業/廠房/設備,總計 - 淨額 | 0 | ||||
其他長期資産,總計 | 0.331 | 0 | |||
流動負債總額 | 17.892 | 10.408 | 3.008 | 0.139958 | 1.9612 |
應付賬款 | 2.111 | 4.178 | 2.022 | 0.139958 | 1.9612 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
負債總額 | 19.076 | 12.338 | 5.651 | 0.192458 | 1.9612 |
長期債務總額 | 0 | 0 | 0 | 0 | 0 |
總權益 | 150.917 | 151.664 | 75.868 | 2.64847 | 10.0003 |
普通股 | 0 | 0 | 5.37358 | 15.3218 | |
額外實收資本 | 344.758 | 288.29 | 120.22 | 0.772294 | |
留存收益(累計赤字) | -194.468 | -137.672 | -44.636 | -3.53096 | -5.32143 |
其他權益,總計 | 0.627 | 1.046 | 0.284 | 0.033559 | |
總負債和股東權益 | 169.993 | 164.002 | 81.519 | 2.84093 | 11.9615 |
已發行普通股總數 | 37.9791 | 28.1022 | 20.96 | 0.40552 | 11.0999 |
其他負債,總計 | 1.184 | 1.93 | 2.643 | 0.052501 | 0 |
其他流動資産,總計 | 2.79786 | 3.6859 | |||
現金 | 142.142 | 133.539 | 80.094 | 3.01645 | |
無形資産,淨額 | 3.689 | 6.869 | 0 | 5.225 | |
商譽,淨額 | 19.918 | 19.918 | 0 | ||
預提費用 | 5.877 | 6.23 | 0.986 | ||
其他流動負債,總計 | 9.904 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
流動資産總額 | 120.086 | 119.791 | 132.413 | 146.055 | 156.51 |
現金和短期投資 | 117.699 | 116.895 | 129.409 | 142.142 | 154.519 |
現金 | 117.699 | 116.895 | 129.409 | 142.142 | 154.519 |
預付的費用 | 2.387 | 2.896 | 3.004 | 3.913 | 1.826 |
其他流動資産,總計 | 0.165 | ||||
總資産 | 141.55 | 142.085 | 155.529 | 169.993 | 180.907 |
物業/廠房/設備,總計 - 淨額 | |||||
商譽,淨額 | 19.918 | 19.918 | 19.918 | 19.918 | 19.918 |
無形資産,淨額 | 1.317 | 2.108 | 2.898 | 3.689 | 4.479 |
流動負債總額 | 31.154 | 35.121 | 24.096 | 17.892 | 26.038 |
應付賬款 | 7.686 | 8.577 | 2.32 | 2.111 | 0.824 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
負債總額 | 45.571 | 36.113 | 25.185 | 19.076 | 27.314 |
長期債務總額 | 14.068 | 0 | 0 | 0 | 0 |
遞延所得稅 | |||||
總權益 | 95.979 | 105.972 | 130.344 | 150.917 | 153.593 |
普通股 | 0 | 0 | 0 | 0 | 0 |
額外實收資本 | 361.538 | 354.023 | 348.986 | 344.758 | 342.415 |
留存收益(累計赤字) | -266.336 | -248.413 | -219.283 | -194.468 | -189.565 |
其他權益,總計 | 0.777 | 0.362 | 0.641 | 0.627 | 0.743 |
總負債和股東權益 | 141.55 | 142.085 | 155.529 | 169.993 | 180.907 |
已發行普通股總數 | 40.0947 | 38.8072 | 38.2901 | 37.9791 | 37.5411 |
預提費用 | 9.957 | 9.95 | 6.687 | 5.877 | 7.467 |
其他負債,總計 | 0.349 | 0.992 | 1.089 | 1.184 | 1.276 |
其他流動負債,總計 | 13.511 | 16.594 | 15.089 | 9.904 | 17.747 |
其他長期資産,總計 | 0.229 | 0.268 | 0.3 | 0.331 | |
長期債務 | 14.068 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2019 | |
---|---|---|---|---|---|
淨收入/起跑線 | -56.796 | -93.036 | -33.937 | -1.10477 | -5.47421 |
經營活動産生的現金 | -50.139 | -45.824 | -23.597 | -0.206066 | -3.19971 |
經營活動産生的現金 | 0.006618 | ||||
非現金物品 | 7.079 | 42.716 | 8.279 | 0.686323 | 0.0725 |
營運資金的變化 | -3.602 | 3.037 | 2.061 | 0.205774 | 1.927 |
投資活動産生的現金 | 0 | -0.297 | 0 | -0.211048 | |
資本支出 | -0.310361 | ||||
其他投資現金流量項目,總計 | 0 | -0.297 | 0 | 0.099313 | |
融資活動産生的現金 | 59.051 | 98.824 | 96.704 | 0.285516 | 9.90205 |
股票的發行(報廢),淨額 | 59.458 | 98.824 | 97.099 | 0.285516 | 9.90205 |
債務的發行(退還),淨額 | 0 | ||||
外彙效應 | -0.309 | 0.742 | 0.284 | -0.001382 | |
現金淨變化 | 8.603 | 53.445 | 73.391 | -0.132972 | 6.70234 |
Amortization | 3.18 | 2.616 | 0 | 0.275 | |
Deferred Taxes | 0 | -1.157 | 0 | ||
融資現金流項目 | -0.407 | 0 | -0.395 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -24.815 | -56.796 | -51.893 | -35.408 | -18.451 |
Cash From Operating Activities | -13.331 | -50.139 | -37.29 | -27.993 | -12.866 |
Amortization | 0.791 | 3.18 | 2.39 | 1.6 | 0.78 |
Non-Cash Items | 8.967 | 7.079 | 13.861 | 8.062 | 3.792 |
Changes in Working Capital | 1.726 | -3.602 | -1.648 | -2.247 | 1.013 |
Cash From Investing Activities | 0 | 0 | 0 | 0 | |
Other Investing Cash Flow Items, Total | 0 | 0 | 0 | 0 | |
Cash From Financing Activities | 0.583 | 59.051 | 58.635 | 0.424 | -0.166 |
Financing Cash Flow Items | 0 | -0.407 | -0.407 | -0.407 | -0.407 |
Issuance (Retirement) of Stock, Net | 0.583 | 59.458 | 59.042 | 0.831 | 0.241 |
Foreign Exchange Effects | 0.015 | -0.309 | -0.365 | -0.229 | -0.035 |
Net Change in Cash | -12.733 | 8.603 | 20.98 | -27.798 | -13.067 |
Capital Expenditures | |||||
Deferred Taxes | 0 |
投資者名稱 | 投資者類型 | 流通股百分比 | 持有股份 | 股份變動 | 持有日期 | 換手率 |
---|---|---|---|---|---|---|
Samberg (Joseph Daniel) | Individual Investor | 2.6815 | 1065000 | 1065000 | 2022-09-28 | MED |
Alyeska Investment Group, L.P. | Hedge Fund | 2.0066 | 796962 | -245677 | 2023-06-30 | HIGH |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 1.4298 | 567885 | -6054 | 2023-06-30 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.3181 | 523522 | 94219 | 2023-06-30 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.9341 | 371010 | 30955 | 2023-06-30 | LOW |
Horizons ETFs Management (Canada) Inc. | Investment Advisor/Hedge Fund | 0.5943 | 236020 | -40045 | 2023-09-30 | MED |
Busey Wealth Management, Inc. | Investment Advisor | 0.5195 | 206320 | -38027 | 2023-09-30 | LOW |
Sullivan (Mark R) | Individual Investor | 0.5036 | 200000 | 200000 | 2023-04-13 | LOW |
Empery Asset Management, L.P. | Investment Advisor/Hedge Fund | 0.4721 | 187500 | 187500 | 2022-09-30 | LOW |
Charles Schwab Investment Management, Inc. | Investment Advisor | 0.4527 | 179809 | 859 | 2023-06-30 | LOW |
Wernli (Miriam Halperin) | Individual Investor | 0.4349 | 172740 | 100000 | 2023-03-14 | LOW |
Cresset Asset Management, LLC | Investment Advisor/Hedge Fund | 0.4016 | 159499 | 159499 | 2023-06-30 | HIGH |
Two Sigma Investments, LP | Hedge Fund | 0.3972 | 157744 | -10441 | 2023-06-30 | HIGH |
Liao (Carrie Feng ju) | Individual Investor | 0.3243 | 128790 | 75000 | 2023-03-14 | |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.3072 | 122000 | 0 | 2023-06-30 | LOW |
DCVC Management Co, LLC | Venture Capital | 0.2527 | 100350 | 0 | 2023-06-30 | LOW |
Telemetry Investments, L.L.C. | Hedge Fund | 0.2417 | 96000 | -9500 | 2022-12-31 | HIGH |
AdvisorShares Investments, LLC | Investment Advisor | 0.23 | 91364 | -1946 | 2023-06-30 | HIGH |
Hu (Cynthia Wong) | Individual Investor | 0.2014 | 80000 | 80000 | 2022-03-24 | |
Karlin (Daniel Rollings) | Individual Investor | 0.1841 | 73114 | -6918 | 2023-09-25 | LOW |
差價合約交易計算器
計算您的假設損益
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
投資
交易規模(槓桿 x 投資):
打開
關閉
做空 做多
Industry: | Biotechnology & Medical Research (NEC) |
One World Trade Center
Suite 8500
NEW YORK
NEW YORK 10007
US
收入報表
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 570.000 多名交易者,選擇與 Capital.com 交易